Squarepoint
ICVX

Squarepoint’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Squarepoint’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,925
Closed -$101K – 3714
2022
Q3 		$101K Buy
+31,925
New +$200K ﹤0.01% 2795

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Squarepoint's ICVX Position: Q4 2022 in Review

Squarepoint sold out of Icosavax, Inc. Common Stock (ICVX) in Q4 2022, closing a stake of 31,925 shares — an estimated $101K sold.

Squarepoint first reported a position in ICVX in Q3 2022 and held it in 1 quarter. The position peaked at $101K in Q3 2022. 65 funds tracked by Wall St. Rank hold ICVX as of Q4 2022.

  • Squarepoint reported no remaining Icosavax, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Squarepoint sold 31,925 Icosavax, Inc. Common Stock shares in Q4 2022, an estimated $101K.
  • Squarepoint first reported a position in Icosavax, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Squarepoint's Icosavax, Inc. Common Stock position peaked at $101K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q4 2022.

Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.